Literature DB >> 20924409

Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Bernard Bonaïti1, Valérie Bonadona, Hervé Perdry, Nadine Andrieu, Catherine Bonaïti-Pellié.   

Abstract

Some diseases are due to germline mutations in predisposing genes, such as cancer family syndromes. Precise estimation of the age-specific cumulative risk (penetrance) for mutation carriers is essential for defining prevention strategies. The genotype-restricted likelihood (GRL) method is aimed at estimating penetrance from multiple case families with such a mutation. In this paper, we proposed an extension of the GRL to account for multiple trait disease and to allow for a parent-of-origin effect. Using simulations of pedigrees, we studied the properties of this method and the effect of departures from underlying hypotheses, misspecification of disease incidence in the general population or misspecification of the index case, and penetrance heterogeneity. In contrast with the previous version of the GRL, accounting for multiple trait disease allowed unbiased estimation of penetrance. We also showed that accounting for a parent-of-origin effect allowed a powerful test for detecting this effect. We found that the GRL method was robust to misspecification of disease incidence in the population, but that misspecification of the index case induced a bias in some situations for which we proposed efficient corrections. When ignoring heterogeneity, the penetrance estimate was biased toward that of the highest risk individuals. A homogeneity test performed by stratifying the families according to the number of affected members was shown to have low power and seems useless for detecting such heterogeneity. These extensions are essential to better estimate the risk of diseases and to provide valid recommendations for the management of patients.

Entities:  

Mesh:

Year:  2010        PMID: 20924409      PMCID: PMC3025788          DOI: 10.1038/ejhg.2010.158

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  28 in total

1.  Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods.

Authors:  P Kraft; D C Thomas
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene.

Authors:  Martina Klutz; Dieter Brockmann; Dietmar R Lohmann
Journal:  Am J Hum Genet       Date:  2002-05-09       Impact factor: 11.025

3.  Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.

Authors:  Jérôme Carayol; Catherine Bonaïti-Pellié
Journal:  Genet Epidemiol       Date:  2004-09       Impact factor: 2.135

4.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

5.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Authors:  Valérie Bonadona; Bernard Bonaïti; Sylviane Olschwang; Sophie Grandjouan; Laetitia Huiart; Michel Longy; Rosine Guimbaud; Bruno Buecher; Yves-Jean Bignon; Olivier Caron; Chrystelle Colas; Catherine Noguès; Sophie Lejeune-Dumoulin; Laurence Olivier-Faivre; Florence Polycarpe-Osaer; Tan Dat Nguyen; Françoise Desseigne; Jean-Christophe Saurin; Pascaline Berthet; Dominique Leroux; Jacqueline Duffour; Sylvie Manouvrier; Thierry Frébourg; Hagay Sobol; Christine Lasset; Catherine Bonaïti-Pellié
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

6.  Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated.

Authors:  J Carayol; M Khlat; J Maccario; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

7.  Cancer risk associated with germline DNA mismatch repair gene mutations.

Authors:  M G Dunlop; S M Farrington; A D Carothers; A H Wyllie; L Sharp; J Burn; B Liu; K W Kinzler; B Vogelstein
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

8.  A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.

Authors:  A C Antoniou; P D P Pharoah; G McMullan; N E Day; M R Stratton; J Peto; B J Ponder; D F Easton
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

9.  Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation.

Authors:  Jane Green; Mary O'Driscoll; Adam Barnes; Eamonn R Maher; Peter Bridge; Keith Shields; Patrick S Parfrey
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

Review 10.  [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].

Authors:  François Eisinger; Brigitte Bressac; Damienne Castaigne; Pierre-Henri Cottu; Jacques Lansac; Jean-Pierre Lefranc; Anne Lesur; Catherine Noguès; Janine Pierret; Séverine Puy-Pernias; Hagay Sobol; Anne Tardivon; Henri Tristant; Richard Villet
Journal:  Bull Cancer       Date:  2004-03       Impact factor: 1.276

View more
  1 in total

Review 1.  New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.

Authors:  A Talhouk; J N McAlpine
Journal:  Gynecol Oncol Res Pract       Date:  2016-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.